Heinrich Höfler
#143,761
Most Influential Person Now
Heinrich Höfler's AcademicInfluence.com Rankings
Heinrich Höflerbiology Degrees
Biology
#10315
World Rank
#13634
Historical Rank
Cell Biology
#484
World Rank
#496
Historical Rank
Genetics
#1083
World Rank
#1182
Historical Rank
Molecular Biology
#1493
World Rank
#1520
Historical Rank
Download Badge
Biology
Heinrich Höfler's Degrees
- PhD Molecular Biology University of Vienna
- Masters Biochemistry University of Vienna
- Bachelors Biology University of Vienna
Similar Degrees You Can Earn
Why Is Heinrich Höfler Influential?
(Suggest an Edit or Addition)Heinrich Höfler's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. (1994) (845)
- PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. (2007) (774)
- Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy (2003) (611)
- Mutations of the human E‐cadherin (CDH1) gene (1998) (610)
- Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. (2002) (607)
- Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans (2006) (580)
- Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. (2001) (528)
- HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing (2010) (465)
- Revised classification of neuroendocrine tumours of the lung, pancreas and gut (2004) (440)
- Clinical Impact of the Plasminogen Activation System in Tumor Invasion and Metastasis: Prognostic Relevance and Target for Therapy (1997) (427)
- Rapamycin extends murine lifespan but has limited effects on aging. (2013) (313)
- MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology (2008) (308)
- [German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. (2011) (287)
- Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. (1999) (281)
- Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele. (2002) (278)
- Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer. (1995) (255)
- Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry. (2010) (248)
- Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3026 patients over a 25-year time period (2008) (243)
- Revised classification of neuroendocrine tumors of the lung, pancreas and gut. (1994) (234)
- Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility (1999) (212)
- Prognostic factors of resected adenocarcinoma of the esophagus. (1995) (211)
- Aurora Kinase A Messenger RNA Overexpression Is Correlated with Tumor Progression and Shortened Survival in Head and Neck Squamous Cell Carcinoma (2006) (204)
- Introducing the German Mouse Clinic: open access platform for standardized phenotyping (2005) (192)
- Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma (1998) (182)
- Quantitative protein analysis from formalin‐fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis (2007) (179)
- Local staging and assessment of resectability in carcinoma of the esophagus, stomach, and duodenum by endoscopic ultrasonography. (1992) (177)
- Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer (2005) (176)
- Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence. (2000) (168)
- Nucleic acids from long-term preserved FFPE tissues are suitable for downstream analyses (2012) (168)
- Gastric adenocarcinoma: pathomorphology and molecular pathology (2001) (152)
- Differentiation and proliferation patterns in human trophoblast revealed by c-erbB-2 oncogene product and EGF-R. (1993) (150)
- Comparison of automated silver enhanced in situ hybridisation (SISH) and fluorescence ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of American Pathologists (2007) (149)
- In vivo histopathology for detection of gastrointestinal neoplasia with a portable, confocal miniprobe: an examiner blinded analysis. (2007) (147)
- The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients (2007) (146)
- Endoscopic ultrasound criteria for vascular invasion in the staging of cancer of the head of the pancreas: a blind reevaluation of videotapes. (2000) (144)
- Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization. (1998) (140)
- Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. (1999) (138)
- The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas (2006) (135)
- Analysis of mammalian gene function through broad based phenotypic screens across a consortium of mouse clinics (2015) (135)
- Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging. (2012) (134)
- MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer. (2011) (132)
- Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc (1999) (131)
- Analysis of the E-Cadherin Repressor Snail in Primary Human Cancers (2007) (130)
- Biopsy surveillance is still necessary in patients with Barrett’s oesophagus despite new endoscopic imaging techniques (2003) (130)
- Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways (2014) (129)
- Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer. (2005) (127)
- Gene rearrangement and Chernobyl related thyroid cancers (2000) (126)
- Cytokeratin expression in simple epithelia. III. Detection of mRNAs encoding human cytokeratins nos. 8 and 18 in normal and tumor cells by hybridization with cDNA sequences in vitro and in situ. (1986) (125)
- Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy. (2001) (120)
- You get what you expect? A critical appraisal of imaging methodology in endosonographic cancer staging (2002) (119)
- Single-cell mutation analysis of tumors from stained histologic slides. (1996) (117)
- DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer. (2011) (117)
- MALDI imaging mass spectrometry for direct tissue analysis: technological advancements and recent applications (2011) (115)
- Quality Assurance in Immunohistochemistry: Results of an Interlaboratory Trial Involving 172 Pathologists (2002) (114)
- De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry (2015) (114)
- Tissue‐based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer (2012) (113)
- Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues (2012) (112)
- Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect (1995) (111)
- Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients (2004) (110)
- Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: Evidence of genetic resemblance by CGH (2000) (109)
- Invasion factors uPA/PAI-1 and HER2 status provide independent and complementary information on patient outcome in node-negative breast cancer. (2003) (109)
- No Evidence for Mutations in the α- and β-Catenin Genes in Human Gastric and Breast Carcinomas (1996) (106)
- Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma. (2005) (106)
- Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. (1993) (105)
- Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping (2012) (104)
- Recessive transmission of a multiple endocrine neoplasia syndrome in the rat. (2002) (103)
- Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events. (2003) (100)
- Desmoglein 2 is expressed abnormally rather than mutated in familial and sporadic gastric cancer (2005) (100)
- Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2. (1995) (100)
- MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma. (2012) (99)
- Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe (1996) (98)
- Prognostic Significance of Free Peritoneal Tumor Cells in the Peritoneal Cavity Before and After Neoadjuvant Chemotherapy in Patients with Gastric Carcinoma Undergoing Potentially Curative Resection (2010) (98)
- Prognostic implications of the seventh edition of the international union against cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institution. (2013) (97)
- Microsatellite instability in adenocarcinomas of the upper gastrointestinal tract. Relation to clinicopathological data and family history. (1995) (97)
- Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up (1999) (96)
- HER-2/neu gene amplification by FISH predicts poor survival in Barrett's esophagus-associated adenocarcinoma. (2000) (94)
- Decentral gene expression analysis for ER+/Her2− breast cancer: results of a proficiency testing program for the EndoPredict assay (2012) (93)
- Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study (2006) (93)
- The role of the pathologist in tissue banking: European Consensus Expert Group Report (2010) (87)
- Epidermal growth factor receptor expression correlates with poor survival in gastric adenocarcinoma from Mexican patients: a multivariate analysis using a standardized immunohistochemical detection system (2004) (86)
- Expression and nuclear localization of Snail, an E-cadherin repressor, in adenocarcinomas of the upper gastrointestinal tract (2006) (86)
- Radical Transhiatal Esophagectomy with Two-Field Lymphadenectomy and Endodissection for Distal Esophageal Adenocarcinoma (1997) (85)
- Cervical pregnancy: Case reports and current concepts in diagnosis and treatment (2004) (85)
- MALDI imaging mass spectrometry in cancer research: combining proteomic profiling and histological evaluation. (2013) (84)
- Pilomatrix carcinoma with multiple visceral metastases: Report of a case (1996) (84)
- Neoexpression of N‐cadherin in E‐cadherin positive colon cancers (2004) (82)
- Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations. (2008) (82)
- CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds. (1998) (82)
- Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer. (2000) (82)
- Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome. (1999) (81)
- Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer (2014) (81)
- Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma. (2003) (80)
- Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody. (1999) (79)
- Combined GADD45A and Thymidine Phosphorylase Expression Levels Predict Response and Survival of Neoadjuvant-Treated Gastric Cancer Patients (2005) (77)
- Combined analysis of Rac1, IQGAP1, Tiam1 and E-cadherin expression in gastric cancer (2008) (76)
- The E-cadherin Repressor Snail Plays a Role in Tumor Progression of Endometrioid Adenocarcinomas (2007) (76)
- Tenascin-C Enhances Pancreatic Cancer Cell Growth and Motility and Affects Cell Adhesion through Activation of the Integrin Pathway (2011) (75)
- Association of Pretherapeutic Expression of Chemotherapy-Related Genes with Response to Neoadjuvant Chemotherapy in Barrett Carcinoma (2005) (75)
- Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections. (2002) (73)
- Classification of HER2/neu status in gastric cancer using a breast-cancer derived proteome classifier. (2010) (73)
- Multicenter Immunohistochemical ALK-Testing of Non–Small-Cell Lung Cancer Shows High Concordance after Harmonization of Techniques and Interpretation Criteria (2014) (72)
- Invasion marker PAI‐1 remains a strong prognostic factor after long‐term follow‐up both for primary breast cancer and following first relapse (1999) (72)
- Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria (2013) (72)
- Microsatellite instability and loss of heterozygosity in melanoma. (1995) (69)
- Infrequent mutations of the p53 gene in pulmonary carcinoid tumors. (1993) (69)
- The Munich Barrett follow up study: suspicion of Barrett’s oesophagus based on either endoscopy or histology only—what is the clinical significance? (2004) (69)
- Chromosomal changes during development and progression of prostate adenocarcinomas (2001) (69)
- Analysis for microsatellite instability and mutations of the DNA mismatch repair gene hMLH1 in familial gastric cancer (1996) (69)
- Identification of p53 gene mutations in gastrointestinal and pancreatic carcinoids by nonradioisotopic SSCA (1993) (68)
- Histone Deacetylase (HDAC) 1 and 2 Expression and Chemotherapy in Gastric Cancer (2010) (68)
- Genetic heterogeneity in a prostatic carcinoma and associated prostatic intraepithelial neoplasia as demonstrated by combined use of laser-microdissection, degenerate oligonucleotide primed PCR and comparative genomic hybridization (1998) (68)
- Cytochrome c oxidase subunit 4 isoform 2‐knockout mice show reduced enzyme activity, airway hyporeactivity, and lung pathology (2012) (68)
- Measles virus in otosclerosis and the specific immune response of the inner ear. (1996) (67)
- Her-2/neu Gene Amplification, Elevated mRNA Expression, and Protein Overexpression in the Metaplasia-Dysplasia-Adenocarcinoma Sequence of Barrett’s Esophagus (2001) (66)
- Histopathologic assessment of tumor regression after neoadjuvant chemotherapy in advanced-stage ovarian cancer. (2007) (65)
- Gastrointestinal mesenchymal tumors – immunophenotypic classification and survival analysis (2002) (64)
- Ovarian Cancer Cell Proliferation and Motility Is Induced by Engagement of Integrin αvβ3/Vitronectin Interaction (2003) (64)
- Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO) (2011) (63)
- Discordant Bone Marrow Involvement in Diffuse Large B-Cell Lymphoma: Comparative Molecular Analysis Reveals a Heterogeneous Group of Disorders (2003) (63)
- Gastric neuroendocrine neoplasms: tumour clonality and malignancy‐associated large X‐chromosomal deletions (1999) (62)
- Identification of gene signatures for invasive colorectal tumor cells. (2007) (61)
- Array‐based comparative genomic hybridization for the detection of DNA sequence copy number changes in Barrett's adenocarcinoma (2004) (61)
- Argon plasma ablation of gastric inlet patches in the cervical esophagus may alleviate globus sensation: a pilot trial. (2006) (61)
- Progressive loss of PAX9 expression correlates with increasing malignancy of dysplastic and cancerous epithelium of the human oesophagus (2002) (61)
- Prognostic impact of tumor biological factors on survival in node-negative breast cancer. (1998) (61)
- Prevalence and Topography of Lymph Node Metastases in Early Esophageal and Gastric Cancer (2014) (60)
- The German Mouse Clinic: a platform for systemic phenotype analysis of mouse models. (2009) (59)
- 20q13.2 Amplification in intraductal hyperplasia adjacent to in situ and invasive ductal carcinoma of the breast (1999) (59)
- Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome (1997) (59)
- Renal cell carcinomas in trichloroethene(TRI) exposed persons are associated with somatic mutations in the von Hippel-Lindau (VHL) tumour suppressor gene (1997) (58)
- High HSP27 and HSP70 expression levels are independent adverse prognostic factors in primary resected colon cancer (2012) (58)
- Approaching MALDI molecular imaging for clinical proteomic research: current state and fields of application (2010) (58)
- Cadherin–catenin complex and transcription factor Snail-1 in spindle cell carcinoma of the head and neck (2008) (57)
- Mutational spectrum of the p53 gene in human small-cell lung cancer and relationship to clinicopathological data. (1993) (57)
- Identification of differentially expressed proteins in triple-negative breast carcinomas using DIGE and mass spectrometry. (2009) (56)
- The prognostic impact of O6‐Methylguanine‐DNA Methyltransferase (MGMT) promotor hypermethylation in esophageal adenocarcinoma (2006) (56)
- Expression of neu/c-erbB-2 in human brain tumors. (1994) (56)
- S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI Imaging (2012) (56)
- MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion (2013) (56)
- Microsatellite instability and loss of heterozygosity in gastric carcinoma in comparison to family history. (1998) (55)
- The thymidylate synthase tandem repeat promoter polymorphism: A predictor for tumor‐related survival in neoadjuvant treated locally advanced gastric cancer (2006) (55)
- Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer (2005) (55)
- No evidence for mutations in the alpha- and beta-catenin genes in human gastric and breast carcinomas. (1996) (54)
- High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma (2010) (54)
- Significance of HER2 Low-Level Copy Gain in Barrett's Cancer: Implications for Fluorescence In situ Hybridization Testing in Tissues (2007) (54)
- TO-PRO-3 is an optimal fluorescent dye for nuclear counterstaining in dual-colour FISH on paraffin sections (2001) (53)
- Tissue microdissection techniques in quantitative genome and gene expression analyses (2001) (53)
- Frequent somatic allelic inactivation of the E-cadherin gene in gastric carcinomas. (1995) (53)
- Proposal for a Multifactorial Prognostic Score That Accurately Classifies 3 Groups of Gastric Carcinoma Patients With Different Outcomes After Neoadjuvant Chemotherapy and Surgery (2012) (52)
- What's new in "in situ hybridization". (1987) (51)
- Assessment of ErbB2 (Her2) in oesophageal adenocarcinomas: summary of a revised immunohistochemical evaluation system, bright field double in situ hybridisation and fluorescence in situ hybridisation (2011) (50)
- Informatics and Medicine (2008) (50)
- Evidence of measles virus RNA in otosclerotic tissue. (1994) (49)
- Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case–control study (2006) (49)
- Coamplification and coexpression of GRB7 and ERBB2 is found in high grade intraepithelial neoplasia and in invasive Barrett's carcinoma (2004) (49)
- Loss of heterozygosity and microsatellite instability in de novo versus ex-adenoma carcinomas of the colorectum. (1998) (49)
- Single amino acid substitutions in conserved extracellular domains of E-cadherin differ in their functional consequences. (2001) (49)
- The expression of subunits of human chorionic gonadotropin (hCG) by nontrophoblastic, nonendocrine, and endocrine tumors. (1987) (49)
- Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer (2008) (49)
- [Her2 testing in gastric cancer. What is different in comparison to breast cancer?]. (2010) (48)
- Signalling networks associated with urokinase‐type plasminogen activator (uPA) and its inhibitor PAI‐1 in breast cancer tissues: new insights from protein microarray analysis (2011) (47)
- Denaturing High Pressure Liquid Chromatography (DHPLC) for the Analysis of Somatic p53 Mutations (2001) (47)
- Relationship between E‐cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl‐2 expression and Ki‐67 staining in diffuse‐type gastric carcinoma (2003) (46)
- Establishment and characterization of continuous cell line MTC-SK derived from a human medullary thyroid carcinoma. (1990) (46)
- Transcription factors Snail, Slug, Twist, and SIP1 in spindle cell carcinoma of the head and neck (2009) (46)
- Laser-assisted preparation of single cells from stained histological slides for gene analysis (1997) (45)
- Distinct cytogenetic alterations in squamous intraepithelial lesions of the cervix revealed by laser‐assisted microdissection and comparative genomic hybridization (1998) (44)
- Pathology of upper gastrointestinal malignancies. (2004) (44)
- A Comprehensive Antibody Panel for Immunohistochemical Analysis of Formalin-Fixed, Paraffin-Embedded Hematopoietic Neoplasms of Mice: Analysis of Mouse Specific and Human Antibodies Cross-Reactive with Murine Tissue (2007) (44)
- Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer (2006) (44)
- Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney (2005) (44)
- The molecular pathology of Barrett's esophagus. (1999) (43)
- Intraoperative Examination of Sentinel Lymph Nodes by Ultrarapid Immunohistochemistry (2003) (43)
- Glutathione-S-transferase P1, T1 and M1 genetic polymorphisms in neoadjuvant-treated locally advanced gastric cancer: GSTM1-present genotype is associated with better prognosis in completely resected patients (2008) (43)
- Genome-wide analysis of genetic alterations in Barrett's adenocarcinoma using single nucleotide polymorphism arrays (2009) (43)
- Loss of immunohistochemical E-cadherin expression in colon cancer is not due to structural gene alterations (1999) (42)
- [Neuroendocrine (Merkel cell) carcinoma of the skin]. (1982) (42)
- Hypermethylation of hMLH1, HPP1, p14ARF, p16INK4A and APC in primary adenocarcinomas of the small bowel (2005) (41)
- Immunohistochemistry of folliculo-stellate cells in normal human adenohypophyses and in pituitary adenomas (2004) (41)
- Chromosomal Imbalances are Associated with Metastasis-Free Survival in Breast Cancer Patients (2002) (41)
- Intratumoral heterogeneity of microRNA expression in breast cancer. (2012) (40)
- Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors—correlation to tumor histopathology and clinical follow-up (2006) (40)
- Innovations in phenotyping of mouse models in the German Mouse Clinic (2012) (39)
- Species identification of mycobacteria in paraffin-embedded tissues: frequent detection of nontuberculous mycobacteria (2005) (39)
- Characterization of a naturally-occurring p27 mutation predisposing to multiple endocrine tumors (2010) (39)
- Impact of protein tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer. (2011) (38)
- Methylation of Tumor-Related Genes in Neoadjuvant-Treated Gastric Cancer: Relation to Therapy Response and Clinicopathologic and Molecular Features (2007) (38)
- Molecular Genetic Changes in Metastatic Primary Barrett’s Adenocarcinoma and Related Lymph Node Metastases: Comparison with Nonmetastatic Barrett’s Adenocarcinoma (2000) (37)
- Combined production of mucus, amines and peptides by goblet-cell carcinoids of the appendix and ileum. (1984) (37)
- Expression Profiling of Stem Cell-Related Genes in Neoadjuvant-Treated Gastric Cancer: A NOTCH2, GSK3B and β-catenin Gene Signature Predicts Survival (2012) (37)
- Widespread microsatellite instability in sebaceous tumours of patients with the Muir‐Torre syndrome (1997) (37)
- Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma (2010) (37)
- Expression of vesicular monoamine transporters, synaptosomal-associated protein 25 and syntaxin1: a signature of human small cell lung carcinoma. (2001) (37)
- A Multicenter Study to Validate the Reproducibility of MSI Testing With a Panel of 5 Quasimonomorphic Mononucleotide Repeats (2010) (37)
- Comparison of loss of heterozygosity and microsatellite instability in adenocarcinomas of the distal esophagus and proximal stomach (2000) (36)
- Activation of epidermal growth factor receptor results in Snail protein but not mRNA overexpression in endometrial cancer (2008) (36)
- Epidermal growth factor receptor, phosphatidylinositol-3-kinase catalytic subunit/PTEN, and KRAS/NRAS/BRAF in primary resected esophageal adenocarcinomas: loss of PTEN is associated with worse clinical outcome. (2013) (36)
- Ras gene mutations: a rare event in nonmetastatic primary malignant melanoma. (1995) (36)
- Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma. (1995) (36)
- E-cadherin expression in sporadic gastric cancer from Mexico: exon 8 and 9 deletions are infrequent events associated with poor survival. (2005) (36)
- Heterogeneous Chromosomal Aberrations in Intraductal Breast Lesions Adjacent to Invasive Carcinoma (2000) (35)
- EXPRESSION OF bcl‐2 AND p53 IN DE NOVO AND EX‐ADENOMA COLON CARCINOMA: A COMPARATIVE IMMUNOHISTOCHEMICAL STUDY (1996) (35)
- Identification of low-risk node-negative breast cancer patients by tumor biological factors PAI-1 and cathepsin L. (1998) (35)
- Immunohistochemical demonstration of cytokeratins in endocrine cells of the human pituitary gland and in pituitary, adenomas (2004) (35)
- Relevance of MET activation and genetic alterations of KRAS and E-cadherin for cetuximab sensitivity of gastric cancer cell lines (2012) (35)
- Loss of heterozygosity and microsatellite instability as predictive markers for neoadjuvant treatment in gastric carcinoma. (2000) (34)
- Association of amphiregulin with the cetuximab sensitivity of gastric cancer cell lines. (2012) (34)
- In situ quantification of HER2–protein tyrosine kinase 6 (PTK6) protein–protein complexes in paraffin sections from breast cancer tissues (2010) (34)
- A specific expression profile of heat-shock proteins and glucose-regulated proteins is associated with response to neoadjuvant chemotherapy in oesophageal adenocarcinomas (2013) (33)
- The impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) in human breast cancer (2013) (33)
- Expression of class I histone deacetylases (HDAC1 and HDAC2) in oesophageal adenocarcinomas: an immunohistochemical study (2010) (32)
- Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial (2008) (32)
- Guided protein extraction from formalin‐fixed tissues for quantitative multiplex analysis avoids detrimental effects of histological stains (2008) (32)
- THE DIAGNOSTIC POTENTIAL OF THE CHROMOSOME TRANSLOCATION t(2;13) IN RHABDOMYOSARCOMA: A PCR STUDY OF FRESH‐FROZEN AND PARAFFIN‐EMBEDDED TUMOUR SAMPLES (1996) (32)
- Comparative FISH analysis of numerical chromosome 7 abnormalities in 5-μm and 15-μm paraffin-embedded tissue sections from prostatic carcinoma (1997) (31)
- Interaction of Snail and p38 mitogen-activated protein kinase results in shorter overall survival of ovarian cancer patients (2010) (31)
- The neuroendocrine system of normal human appendix, ileum and colon, and in neurogenic appendicopathy (2004) (31)
- Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome. (2012) (31)
- Stromelysin-3 expression in invasive ovarian carcinomas and tumours of low malignant potential (2000) (31)
- Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean population (2003) (31)
- Evidence of Prognostic Relevant Expression Profiles of Heat-Shock Proteins and Glucose-Regulated Proteins in Oesophageal Adenocarcinomas (2012) (31)
- Simultaneous localization of calcitonin mRNA and peptide in a medullary thyroid carcinoma (1987) (30)
- uPA and PAI-1-Related Signaling Pathways Differ between Primary Breast Cancers and Lymph Node Metastases. (2012) (30)
- Paclitaxel in the Neoadjuvant Treatment for Adeno carcinoma of the Distal Esophagus (AEG I). A Comparison of Two Phase II Trials with Long-Term Follow-Up (2008) (30)
- Chromogranin A and B gene expression in carcinomas of the breast. Correlation of immunocytochemical, immunoblot, and hybridization analyses. (1990) (30)
- Genetic Alterations in Presumptive Precursor Lesions of Breast Carcinomas (2002) (29)
- [The endosonographic staging of pancreatic carcinoma]. (2008) (29)
- Clinical proteomics: new trends for protein microarrays. (2006) (29)
- p53 Alterations in thymic epithelial tumours (1997) (29)
- Evaluation of C-ErbB-2 Overexpression and Her-2/neu Gene Copy Number Heterogeneity in Barrett’s Adenocarcinoma (2000) (29)
- Self-sustained sequence replication (3SR): an alternative to PCR (1997) (29)
- Quantification of CK20 gene and protein expression in colorectal cancer by RT‐PCR and immunohistochemistry reveals inter‐ and intratumour heterogeneity (2002) (29)
- Fibrovascular esophageal polyp as a diagnostic challenge. (2000) (28)
- Genetic aberrations in primary esophageal melanomas: molecular analysis of c-KIT, PDGFR, KRAS, NRAS and BRAF in a series of 10 cases (2011) (28)
- Functional allelic loss detected at the protein level in archival human tumours using allele‐specific E‐cadherin monoclonal antibodies (2002) (28)
- Disruption of the murine p53 gene by insertion of an endogenous retrovirus-like element (ETn) in a cell line from radiation-induced osteosarcoma. (1994) (28)
- Herpesvirus 8‐Associated Penile Kaposi's Sarcoma in an HIV‐Negative Patient: First Report Of A Solitary Lesion (2003) (28)
- Direct molecular tissue analysis by MALDI imaging mass spectrometry in the field of gastrointestinal disease. (2012) (27)
- Bone marrow involvement in follicular lymphoma: Comparison of histology and flow cytometry as staging procedures (2006) (27)
- Common Protein Biomarkers Assessed by Reverse Phase Protein Arrays Show Considerable Intratumoral Heterogeneity in Breast Cancer Tissues (2012) (27)
- Evaluation of colon cancer histomorphology: a comparison between formalin and PAXgene tissue fixation by an international ring trial (2014) (27)
- Immunocytochemistry in cytology. Comparative evaluation of different techniques. (1989) (27)
- Comparison of pretherapeutic and posttherapeutic expression levels of chemotherapy-associated genes in adenocarcinomas of the esophagus treated by 5-fluorouracil- and cisplatin-based neoadjuvant chemotherapy. (2007) (27)
- In situ amplification of measles virus RNA by the self-sustained sequence replication reaction. (1995) (27)
- Influence of tumor-associated E-cadherin mutations on tumorigenicity and metastasis. (2003) (26)
- Stromelysin‐3 (ST‐3) mRNA Expression in Colorectal Carcinomas: Localization and Clinicopathologic Correlations (1996) (26)
- Preoperative staging of gastric cancer as precondition for multimodal treatment (1995) (26)
- Gastric Cancer. (1977) (25)
- Precise measurement of the E-cadherin repressor Snail in formalin-fixed endometrial carcinoma using protein lysate microarrays (2008) (25)
- Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tract. (2006) (25)
- CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma. (2009) (25)
- Expression cloning of the cDNA encoding a melanoma-associated Ag recognized by mAb HMB-45. Identification as melanocyte-specific Pmel 17 cDNA. (1995) (24)
- Central European Cooperative Oncology Group (2010) (24)
- Profiling signalling pathways in formalin‐fixed and paraffin‐embedded breast cancer tissues reveals cross‐talk between EGFR, HER2, HER3 and uPAR (2012) (24)
- Expression of c-myc and c-fos mRNA in colorectal carcinoma in man (1990) (23)
- Combined cytogenetic and molecular genetic analyses of fifty-nine untreated human prostate carcinomas. (1996) (23)
- Laser beam microdissection in the diagnosis of cutaneous B‐cell lymphoma (1997) (23)
- Increasing chromosome 1 copy number parallels histological progression in breast carcinogenesis (2000) (23)
- Detection of small RB1 gene deletions in retinoblastoma by multiplex PCR and high-resolution gel electrophoresis (1992) (22)
- A Multifactorial Histopathologic Score for the Prediction of Prognosis of Resected Esophageal Adenocarcinomas After Neoadjuvant Chemotherapy (2014) (22)
- Peripheral primitive neuroectodermal tumor of the stomach in a 14-year-old boy: a case report (2004) (22)
- Two novel tumor suppressor gene loci on chromosome 6q and 15q in human osteosarcoma identified through comparative study of allelic imbalances in mouse and man (2002) (22)
- Rapid detection of mutated E-cadherin in peritoneal lavage specimens from patients with diffuse-type gastric carcinoma. (1999) (22)
- High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma. (2019) (22)
- Different risk groups in node—negative breast cancer: Prognostic value of cytophotometrically assessed DNA, morphometry and texture (1995) (22)
- Effects of Simultaneous Knockdown of HER2 and PTK6 on Malignancy and Tumor Progression in Human Breast Cancer Cells (2013) (22)
- [Prognostic factors of gastrointestinal stromal tumors of the stomach]. (1998) (22)
- Molecular mechanisms of carcinogenesis in gastric cancer. (2003) (22)
- Stromelysin-3 expression in noninvasive and invasive neoplasms of the urinary bladder. (2000) (21)
- Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors. (2002) (21)
- Effect of Wild-Type and Mutant E-Cadherin on Cell Proliferation and Responsiveness to the Chemotherapeutic Agents Cisplatin, Etoposide, and 5-Fluorouracil (2004) (21)
- Analysis of microsatellite instability and loss of heterozygosity in keratoacanthoma (1997) (21)
- Overexpression of PTK6 (breast tumor kinase) protein—a prognostic factor for long-term breast cancer survival—is not due to gene amplification (2009) (21)
- An ENU mutagenesis-derived mouse model with a dominant Jak1 mutation resembling phenotypes of systemic autoimmune disease. (2013) (21)
- Biclonality of Gastric Lymphomas (2001) (21)
- Differential response of human basophils and mast cells to recombinant chemokines (1995) (21)
- Isolation of the PAX9 cDNA from adult human esophagus (2009) (21)
- Efficiency of Single‐cell Polymerase Chain Reaction from Stained Histologic Slides and Integrity of DNA in Archival Tissue (1997) (20)
- Microdissection of Tissue Sections: Application to the Molecular Genetic Characterisation of Premalignant Lesions (2000) (20)
- Epstein-Barr Virus–Negative Hodgkin's Lymphoma After Mycosis Fungoides: Molecular Evidence for Distinct Clonal Origin (2001) (20)
- Oligoclonality of a "composite" gastric diffuse large B-cell lymphoma with areas of marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type (2002) (20)
- Neuroendocrine neoplasms of the lung are not associated with point mutations at codon 12 of the Ki-ras gene (1993) (20)
- Oncogene expression in endocrine pancreatie tumors (1988) (20)
- Centrosome abnormalities in head and neck squamous cell carcinoma (HNSCC) (2009) (20)
- Antibody validation by combining immunohistochemistry and protein extraction from formalin‐fixed paraffin‐embedded tissues (2012) (20)
- Comparison of different histopathological methods for the examination of sentinel lymph nodes in breast cancer. (2000) (19)
- Extraction of Phosphorylated Proteins from Formalin-Fixed Cancer Cells and Tissues (2008) (19)
- Extraepithelial intraneural endocrine cells as starting-points for gastrointestinal carcinoids (2004) (19)
- C609T polymorphism of the NAD(P)H:quinone oxidoreductase I gene does not significantly affect susceptibility for esophageal adenocarcinoma (2005) (19)
- Pulmonary nodule caused by an alveolar adenoma of the lung (1997) (19)
- Using Q-RT-PCR to measure cyclin D1, TS, TP, DPD, and Her-2/neu as predictors for response, survival, and recurrence in patients with esophageal squamous cell carcinoma following radiochemotherapy (2008) (18)
- Mapping of a cadherin gene cluster to a region of chromosome 5 subject to frequent allelic loss in carcinoma. (1999) (18)
- Sequential Multilocus Fluorescence In Situ Hybridization Can Detect Complex Patterns of Increased Gene Dosage at the Single Cell Level in Tissue Sections (2001) (18)
- Numerical aberrations of chromosome 7 detected in 15 μm paraffin‐embedded tissue sections of primary cutaneous melanomas by fluorescence in situ hybridization and confocal laser scanning microscopy (1997) (18)
- Elevated p53 RNA expression correlates with incomplete osteogenic differentiation of radiation‐induced murine osteosarcomas (1992) (18)
- Dynamics of cell adhesion and motility in living cells is altered by a single amino acid change in E-cadherin fused to enhanced green fluorescent protein. (2004) (18)
- Proteomic and metabolic prediction of response to therapy in gastrointestinal cancers (2009) (18)
- Tumor-associated E-cadherin mutations do not induce Wnt target gene expression, but affect E-cadherin repressors (2004) (18)
- Effect of tumor‐associated mutant E‐cadherin variants with defects in exons 8 or 9 on matrix metalloproteinase 3 (2005) (17)
- Detection of HER-2 oncogene amplification in breast cancer by differential polymerase chain reaction from single cryosections (1993) (17)
- Molecular evidence of bone marrow involvement in advanced case of Tγδ lymphoma with secondary myelofibrosis (1998) (17)
- Mapping the chromosome 16 cadherin gene cluster to a minimal deleted region in ductal breast cancer. (2001) (17)
- Rapid identification of Wilson's disease carriers by denaturing high-performance liquid chromatography. (2002) (16)
- Expression and function of the coxsackie and adenovirus receptor in Barrett's esophagus and associated neoplasia (2009) (16)
- Identification of a low‐risk group of stage I breast cancer patients by cytometrically assessed DNA and nuclear texture parameters (1995) (16)
- Decision impact and feasibility of different ASCO-recommended biomarkers in early breast cancer: Prospective comparison of molecular marker EndoPredict and protein marker uPA/PAI-1 (2017) (16)
- Bone tumor induction after incorporation of short-lived radionuclides (1991) (15)
- Postembedding ultrastructural in situ hybridization on ultrathin cryosections and LR white resin sections. (1993) (15)
- Molecular medicine of gastric adenocarcinomas (2005) (15)
- Fixed archival tissue (1997) (15)
- TYPE‐1 PLASMINOGEN ACTIVATOR INHIBITOR IN HUMAN RENAL CELL CARCINOMA (1996) (15)
- Correlation of Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinase Expression in Ileal Carcinoids, Lymph Nodes and Liver Metastasis with Prognosis and Survival (2008) (15)
- Quality assessment in diagnostic molecular pathology: experience from a German-Austrian-Swiss multicenter trial (2000) (14)
- Oncogene expression in a medullary thyroid carcinoma (1987) (14)
- Comparative FISH analysis of numerical chromosome 7 abnormalities in 5-micron and 15-micron paraffin-embedded tissue sections from prostatic carcinoma. (1997) (14)
- Kinetic profiles of intraepithelial and invasive prostatic neoplasias: the key role of down-regulated apoptosis in tumor progression (2000) (14)
- [Oncogene expression in endocrine pancreatic tumors]. (1987) (13)
- B3 Lesions: Radiological Assessment and Multi-Disciplinary Aspects (2010) (13)
- Human pheochromocytomas show reduced p27Kip1 expression that is not associated with somatic gene mutations and rarely with deletions (2007) (13)
- Duodenal microgastrinomas associated with Zollinger-Ellison syndrome. (1996) (13)
- [Prognostic factors in pancreatic cancer]. (1994) (13)
- [Carcinoma of the oesophagogastric junction and Barrett's esophagus: an almost clear oncologic model?]. (2003) (12)
- Frequent Loss of Heterozygosity at Chromosome 13q12–13 with BRCA2 Markers in Sporadic Male Breast Cancer (1998) (12)
- Additive impact of HER2‐/PTK6‐RNAi on interactions with HER3 or IGF‐1R leads to reduced breast cancer progression in vivo (2015) (12)
- Localization of somatostatin mRNA in the gut, pancreas and thyroid gland of the rat using antisense RNA probes for in situ hybridization. (1987) (12)
- [Expression of genes of potential importance in the response to chemotherapy in osteosarcoma patients]. (2002) (11)
- Immunoreactivity and expression of amylin in gastroenteropancreatic endocrine tumors. (1993) (11)
- Disease-free survival of node-positive breast cancer patients. Improved prognostication by cytometrical parameters. (1995) (11)
- Two‐phase short‐term culture method for cytogenetic investigations from human prostate carcinoma (1994) (11)
- Esophageal (Barrett's) adenocarcinoma is not associated with Epstein‐Barr virus infection: An analysis of 162 cases (2005) (11)
- Clinical Relevance of T1-S, an Oncogene-Inducible, Secreted Glycoprotein of the Immunoglobulin Superfamily, in Node-Negative Breast Cancer (2001) (11)
- Bilateral stromal Leydig cell tumour of the ovary. Case report and literature review. (1991) (10)
- Staging gastrointestinal cancer as a precondition for multimodal treatment (1995) (10)
- Diagnosis and Prognosis of Neuroendocrine Tumours of the Lung by Means of High Resolution Image Analysis (1999) (9)
- The intermediate filament cytoskeleton of cutaneous neuroendocrine carcinoma (Merkel cell tumour) (2004) (8)
- Comparison of CD44 expression in early colorectal carcinomas of the de novo and ex adenoma types (1998) (8)
- Prognostic significance of p 21 WAF 1 / CIP 1 , p 27 Kip 1 , p 53 and E-cadherin expression in gastric cancer (2007) (8)
- Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases (1996) (8)
- Variation in Cell Signaling Protein Expression May Introduce Sampling Bias in Primary Epithelial Ovarian Cancer (2013) (8)
- In situ polymerase chain reaction: toy or tool? (1993) (8)
- [Prediction of response to neoadjuvant chemotherapy in Barrett's carcinoma by quantitative gene expression analysis]. (2004) (7)
- Immunocytochemistry in Cytology (1988) (7)
- In situ quantification of HER 2-protein tyrosine kinase 6 ( PTK 6 ) protein-protein complexes in paraffin sections from breast cancer tissues (2010) (7)
- [Immunohistochemistry Circle Trial of the University Institute of Pathology in Germany]. (1997) (7)
- [Quantification of messenger RNA expression in tumors: which standard should be used for best RNA normalization?]. (1994) (7)
- [The tumorlet carcinoid in bronchiectasis-changed lungs. An example of a multifocal, endocrine tumor]. (1990) (7)
- Giant Malignant Mesenchymoma of the Spermatic Cord with Bidirectional Differentiation (2001) (7)
- Mutant cell surface receptors as targets for individualized cancer diagnosis and therapy. (2001) (7)
- Pathological Examination of Sentinel Lymph Nodes: Work-Up – Interpretation – Clinical Implications (2007) (6)
- [Incidence and prognostic significance of epithelioid cell reactions and microcarcinoses in regional lymph nodes in stomach carcinoma]. (1997) (6)
- [Surgical therapy of gastrinoma with associated Zollinger-Ellison syndrome]. (1996) (6)
- Molecular evidence of bone marrow involvement in advanced case ot Tgammadelta lymphoma with secondary myelofibrosis. (1998) (6)
- Improved prognostication in small (pT1) breast cancers by image cytometry (2004) (6)
- Endoscopic measurement of Barrett's esophagus length is unreliable - a prospective comparative biopsy study. (2004) (6)
- [Interlaboratory trial 2000 " Immunohistochemistry" of the German Society for Pathology and the Professional Association of German Pathologists]. (2003) (6)
- [Morphologic response evaluation of neoadjuvant chemotherapy of gastric carcinoma]. (2000) (6)
- [Classification of neuroendocrine tumors of the gastrointestinal tract and pancreas and its therapeutic relevance]. (1997) (6)
- Oncogene and receptor expression. (1991) (6)
- Tumor-associated overexpression of the soluble T1-S receptor in lymph node-negative breast cancer. (2000) (6)
- [Oncogene amplification and genetic heterogeneity in the metaplasia-dysplasia-adenocarcinoma sequence of Barrett esophagus]. (2001) (6)
- [Papillary adenoma of type-II pneumocytes as a rare differential diagnosis of a solitary pulmonary nodule]. (2007) (5)
- [Molecular carcinogenesis of the upper gastrointestinal tract]. (2003) (5)
- Expression of c-myc in cutaneous lymphomas and pseudolymphomas. (1991) (5)
- c-myc mRNA expression in non-Hodgkin’s lymphomas (1992) (5)
- Pituitary hyperplasia after goserelin (LHRH–analogue) therapy (1991) (5)
- Analysis of DNA and morphometry in breast carcinoma (1996) (5)
- Molecular diagnosis of a Mycobacterium chelonae infection. (2001) (5)
- Non-radioactive protein truncation test (nrPTT) for rapid detection of gene mutations. (1996) (5)
- Identification of Cyclin D 1 mRNA Overexpression in B-Cell Neoplasias by Real-Time Reverse Transcription-PCR of Microdissected Paraffin Sections 1 (2002) (5)
- [MALDI imaging mass spectrometry for direct tissue analysis]. (2009) (5)
- Immunohistochemical markers in (ganglio)neuroblastomas. (1990) (5)
- Immunocytochemical demonstration of cytokeratin in gastrointestinal carcinoids and their probable precursor cells (2004) (5)
- [Influence of Epstein-Barr virus genome on patient survival in Hodgkin's disease]. (1992) (4)
- Novel multiple, monoallelic KRAS mutations at codon 12 and 13 (2009) (4)
- Complement receptor expression on basophils and mast cells: Evidence for mast cell heterogeneity (1994) (4)
- Substance P in an argentaffin carcinoid of the caecum: Biochemical and biological characterization (2004) (4)
- Detection of epidermal growth factor receptor by scanning electron microscopy (1994) (4)
- Deletion of exon 8 increases cisplatin-induced E-cadherin cleavage. (2008) (4)
- Participation in and support of clinical studies and other scientific investigations - Statement of the German Society for Pathology. (2014) (4)
- Prognostic value of nucleolar organizer regions in neuroendocrine tumours of the lung (2004) (4)
- [Neurogenic appendicopathy - an immunocytochemical study]. (1982) (4)
- Suppression of T1-receptor expression by antisense RNA abrogates differentiation of osteogenic osteosarcoma cells. (1999) (4)
- Endoscopic ultrasound is less accurate in pancreatic cancer staging than previously thought: A blind analysis of videotapes (1996) (3)
- [Hippel-Lindau syndrome and sporadic renal cell carcinomas. Pathogenesis, morphologic spectrum and molecular genetics]. (1995) (3)
- The German Mouse Clinic – Running an Open Access Platform (2011) (3)
- New Molecular Aspects in Gastric Cancer: Possible Clinical Implications (1997) (3)
- Re: clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. (2000) (3)
- Abstract P4-11-27: Prospective comparison of conventional clinicopathological factors, uPA/PAI-1 and EndoPredict®-clin score (EPclin) for adjuvant clinical decision making in ER-positive, HER2-negative breast cancer: Progesterone receptor expression is strongly associat (2015) (3)
- [Guidelines of the German Society for Pathology. Guideline for diagnostic molecular pathology. German Society for Pathology]. (1999) (3)
- [Specific in situ labeling of apoptosis shows different rates of programmed cell death in non-Hodgkin lymphomas]. (1994) (3)
- [Early squamous epithelial carcinoma of the esophagus--multicentricity, metastatic pattern and prognosis]. (1996) (3)
- Imaging of immunolabeled membrane receptors in uncoated SEM specimens. (2008) (3)
- Mapping of a mouse mammary tumor virus integration site by retroviral LTR--arbitrary polymerase chain reaction. (1998) (2)
- [Participation and support of clinical studies and other scientific investigations. Statement of the German Society for Pathology]. (2013) (2)
- [How can the effectiveness of multimodality therapy concepts be evaluated? From the viewpoint of the pathologist]. (2001) (2)
- The Intracellular Domain of Cadherin-11 is not Required for the Induction of Cell Aggregation, Adhesion or Gap-Junction Formation (2001) (2)
- [Pathology of appendicitis]. (2002) (2)
- [Detection of neuroendocrine gene expression of tumor cells by combined in situ hybridization and immunocytochemistry]. (1986) (2)
- MIB-1, AgNOR AND DNA DISTRIBUTION PARAMETERS AND THEIR PROGNOSTIC VALUE IN NEUROENDOCRINE TUMOURS OF THE LUNG (2011) (2)
- Long-term prognostic impact of PAI-1 in primary breast cancer confirmed by six-year median follow-up (1997) (2)
- Immunohistochemical assessment of a testicular tumor in a 63-year-old patient: proposal for an integrated clinicopathologic approach. (2003) (2)
- [Nodular paragranuloma and Epstein-Barr virus: frequency of EBV DNA and clinical relevance]. (1992) (2)
- Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tract. (2007) (2)
- [Diffuse stomach carcinoma: from H&E diagnosis and molecular pathology to specific therapy]. (1999) (2)
- [Oncogene expression in colonic cancers]. (1988) (2)
- In situ hybridization of cytospin preparations: a rapid nonisotopic screening method for isolated cells. (1994) (2)
- Early Carcinomas of the Upper GI-Tract, Abstract 339–346, Symposium (2003) (2)
- EGF-receptor immunolabeling as shown by LM and SEM. (1992) (2)
- In situ hybridization in pathology. (1994) (2)
- Optical Surface and Morphology Inspection Techniques (2008) (2)
- Reply to Letter: “Tumor Regression After Neoadjuvant Chemotherapy in GastricCarcinoma (2014) (1)
- [Novel mutation-specific monoclonal E-cadherin antibodies make possible allele differentiation at the protein level in tumors]. (1999) (1)
- [Role of pathology: tumour banks, quality of tissue and more?]. (2006) (1)
- 668: Predictive value of Notch associated genes for response and survival in neoadjuvant treated gastric cancer (2014) (1)
- Bone marrow histology and flow cytometry (FCM) as staging procedures in follicular lymphoma (FL) (2004) (1)
- Prognostic significance of free peritoneal tumor cells in the peritoneal cavity before and after neoadjuvant chemotherapy in patients with gastric cancer undergoing a potentially curative resection. (2010) (1)
- [Are there differences between ex adenoma and de novo colorectal carcinomas?]. (1999) (1)
- A specific germline mutation in the VHL tumor suppressor gene correlates with pheochromocytoma (1995) (1)
- Screening for Microsatellite Instability in Adenocarcinomas of the Upper Gastrointestinal Tract (1994) (1)
- Neue Techniken in der molekularen Diagnostik (2012) (1)
- Oral squamous cell carcinoma (OSCC) — The role of to the tumor associated proteases uPA, PAI-1, cathepsin D, cathepsin B, cathepsin L and the receptor uPA-R (1997) (1)
- Molecular analysis of gene expression in tumor pathology. (2003) (1)
- 405 Evaluation of B3-lesions diagnosed at percutaneous biopsy and surgical results after excision (2010) (1)
- [Neuroendocrine tumors of the lung]. (1997) (1)
- A case of multiple diffuse gastric carcinoma with regional expression of mutant E-cadherin (2008) (1)
- [Update on protein analysis of fixed tissues]. (2010) (1)
- [Neurogenic appendicopathy. A facultative precursor of appendiceal carcinoids. Contribution to Feyrter's theory of disseminated endocrine-(paracrine) cells]. (1982) (1)
- [Current classification of gastrointestinal stromal tumors]. (2000) (1)
- Extraepithelial origin of gastrointestinal carcinoids (1983) (1)
- Note from the society for histochemistry (2004) (1)
- S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI Imaging (2011) (0)
- Cellular transformation by chemicals and oncogernes gene transfer and phenotypic changes (1989) (0)
- Molecular Genetic Approaches to Early Cancer Detection (1992) (0)
- Surgical results and long-term follow-up in female and male prolactinomas (1985) (0)
- Use of a Newly Developed Ultrarapid Immunohistochemical Method to Improve Security in Sentinel Node Investigation and Timing in Interdisciplinary Cooperation (2005) (0)
- Different mechanism of cyclin D1 and myeov overexpression in multiple myeloma revealed by quantitative analysis of mRNA levels (2003) (0)
- Association of the C609T polymorphism of the NQO1-gene with adenocarcinoma of the distal esophagus (2004) (0)
- The Self-Sustained Sequence Replication (3SR): Amplification of Measles Virus RN A in Vitro in Cell Suspensions and Cytospin Preparations (1994) (0)
- 534: The role of the cell adhesion molecule E-cadherin in cetuximab sensitivity of gastric cancer cell lines (2014) (0)
- [Murine leukemia virus Akv promotes bone tumor development in fos-transgenic mice]. (1994) (0)
- Title Page / Contents / Friedrich Feyrter (1895-1973) / Preface (1984) (0)
- Microarray-based copy number profiling in Barrett's adenocarcinoma (2004) (0)
- Markers for predicting the outcome of anthracycline treatment (2006) (0)
- Flow cytometric analysis of fresh human tumor tissue: A new separation system for identification of single tumor cells and application to analysis of tumor-asssociated proteases (1993) (0)
- mRNA detection by in situ hybridization with radioactive probes. (1989) (0)
- The impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) in human breast cancer (2013) (0)
- Cytokeratin expression in simple epithelia: III. Detection of mRNAs encoding human cytokeratins nos. 8 and 18 in normal and tumor cells by hybridization with cDNA sequences in vitro and in situ (1986) (0)
- [Lectin binding of breast cancers]. (1985) (0)
- [Value of various neuroendocrine cell markers in the immunohistochemical diagnosis of neuroendocrine tumors of the gastroenteropancreatic system]. (1987) (0)
- Process for the treatment of proliferative disorders mammary cells. (2003) (0)
- [The pathologist as the "guide for therapy". Considerations using the example of malignant lung tumors]. (2000) (0)
- [Recommendations for organ/tissue removal and use in research and teaching]. (2004) (0)
- Cutaneous infections with mycobacterium fortuitum complex in HIV negative immunosuppressed patients: comparison of molecular, microbiological and morphological findings (2004) (0)
- Quality assurance in immunohistochemistry. Authors' reply (2003) (0)
- Three-dimensional FISH on thick sections identifies HER2 low-level copy gain as biologically significant in Barrett's cancer (2007) (0)
- Gene expression analysis in association with response and survival of neoadjuvant treated gastric cancers patients (2004) (0)
- Clonality analysis of lymphoid bone marrow infiltrates in chronic myeloproliferative disorders and myelodysplastic syndromes (2004) (0)
- New immunocytochemical observations in prolactinomas (1985) (0)
- of mRNA levels revealed by fluorescence in situ hybridization and quantitative analysis Different mechanisms of cyclin D1 overexpression in multiple myeloma (2013) (0)
- Prospects of Research in Pathology, Abstract 25, State-of-the-art-lecture (2001) (0)
- [Results of reference pathology in mammography screening]. (2008) (0)
- Patients with Recurrent Breast Cancer Aminotransferase with Response to Endocrine Therapy in Association of DNA Methylation of Phosphoserine (2005) (0)
- Cytogenetic analysis of 20 cases of primary cultures of human prostate cancer (1992) (0)
- Contents, Vol. 31, Supplement 2, 1991 (1991) (0)
- [Leave-taking rooms. Ethical, legal and financial considerations]. (2006) (0)
- Differential expression of complement (C−) AGs on human basophils, skin mast cells and other mast cell subsets (1994) (0)
- Jeremy Jass Prize for Research Excellence in Pathology 2015 (2017) (0)
- Impairment of pituitary hormone secretion in patients with prolactinoma (1985) (0)
- Germline and somatic mutations in theVHL tumor suppressor gene (2007) (0)
- Molecular and cytogenetic studies on sporadic and familial forms of renal cell carcinomas : Detection of homozygous loss of the Von Hippel-Lindau tumor-suppressor gene by cytogenetics, PCR/SSCP, FISH with 3p YAC probes and CGH (1995) (0)
- [Central and peripheral carcinoid of the lung. Histogenetic and clinical significance]. (1987) (0)
- Therapy Related Markers and Response Prediction Towards Multimodal Treatment of Carcinomas of the Upper Gastrointestinal Tract (2008) (0)
- Abstract A046: MiR-221 and -222 expression elevates cell invasion and allows distinction between different prognostic groups in advanced breast cancers (2013) (0)
- Detection of the Barrett-Metaplasia-Intraepithelial Neoplasia-Carcinoma sequence in Barrett-patients under endoscopic surveillance (2004) (0)
- [DNA flow cytometric analysis in primary breast cancer. S-phase and ploidy status as prognostic factors and their correlation to tumor-associated proteolytic factors]. (1993) (0)
- [Analysis of signalling pathways in formalin-fixed breast cancer tissues]. (2010) (0)
- 283 Evaluation of thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA levels in colorectal cancer reveals significant correlations to tumor histopathology and disease-free survival in 5-FU treated patients (2003) (0)
- Predictive array analysis of breast cancer (2004) (0)
- [Androgenization in postmenopause in rare ovarian tumors--2 case reports]. (1990) (0)
- [Molecular pathologic diagnosis in solid tumors. What is clinically relevant?]. (2002) (0)
- [Response prediction: molecular approaches and routine clinical care]. (2003) (0)
- detection of point mutations of Ha-ras gene in basaliomas and spinaliomas by the use of polymerase chain reaction (PCR) ANALISI DELLE MUTAZIONI PUNTIFORMI DEL GENE HA-RAS IN BASALIOMI E SPINALIOMI MEDIANTE LA TECNICA DELLA POLYMERASE CHAIN REACTION (PCR) (1989) (0)
- Germline mutations in the E-cadherin and TP53 genes, but not in HPP1 or RUNX3 are associated with genetic predisposition for gastric cancer (2004) (0)
- Predictive Biomarker of ER+/HER2- Breast Cancer - Discrepancies between German S3 Guideline, AGO Recommendation and St. Gallen Opinion of the Experts (2013) (0)
- Introduction to Molecular Medicine, 2nd ed, Dennis W Ross. Springer-Verlag, Berlin - Heidelberg - New York (1996), Softcover DM 42,00; 6S 306,60; sFr 37,50. 0-387-94468-0. (1997) (0)
- The prognostic role of lymphatic vessel invasion in patients with primary resected adenocarcinomas of the esophagogastric junction (2004) (0)
- Clinical relevance of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in oral squamous cell carcinoma (OSCC) (1999) (0)
- [The German Society of Pathology on the threshold of its second century]. (1997) (0)
- Analysis of structural variants of chromosome 9 in two cases of human prostate cancer by fluorescence in situ hybridization (FISH with chromosome-specific DNA probes (1992) (0)
- Wie kann man die Effektivität multimodaler Therapiekonzepte evaluieren? Aus der Sicht des Pathologen / How to Evaluate the Efficacy of Multimodal Therapy Regimens? The Standpoint of the Pathologist (2001) (0)
- [Flow cytometry DNA analysis of pure cell nuclei from formalin fixed paraffin sections in primary breast cancer: correlation with other prognostic factors]. (1991) (0)
- 820: Chemo-resistant gastric cancer: changes in Notch signalling (2014) (0)
- Analysis of genetic instability (“microsatellites”) in malignant melanoma (1994) (0)
- Evidence for complete mutational inactivation of the E-cadherin gene and loss of the wildtype protein in invasive lobular breast carcinoma (1996) (0)
- Proposal for an international multi center study: E-cadherin mutationspecific antibody to detect exon deletion in diffuse type gastric cancer (1997) (0)
- Use of nucleic acids of PITX2 to improve the treatment of proliferative disorders mammary cells (2003) (0)
- Polymorphisms in the nucleotide excision repair genes ERCC1 and ERCC2 and association with response and prognosis in neoadjuvant treated gastric cancer patients (2007) (0)
- Reply to letter: "Tumor regression after neoadjuvant chemotherapy in gastric carcinoma: are there really so few responders?". (2014) (0)
- 673: uPAR and its interaction partners: potential new therapy targets in triple negative breast cancer (2014) (0)
- Histochemical demonstration of lectin binding sites in neuroendocrine tumors. (1988) (0)
- [Oncogenes and oncogene products--possibilities and significance of their detection]. (1990) (0)
- 403 Regulation of matrix metalloproteinase 3 by tumor-associated mutant E-cadherin variants (2004) (0)
- Author's response to reviews Title: High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma Authors: (2010) (0)
- Problematic divergencies between clinical and immunocytochemical findings in prolactinomas (1985) (0)
- Microsatellite instability and mutation of the DNA mismatch repair gene HMLH1 in gastric cancer (1996) (0)
- Intra- and extraepithelial amphicrine cells of the gastrointestinal tract (1983) (0)
- Contents, Vol. 33, Supplement 1, 1993 (1993) (0)
- Genetic finger print analyses in patients with renal carcinomas (1992) (0)
- A letter to young researchers in the biomedical sciences (1993) (0)
- Length polymorphism in the promoter of the thymidylate synthase (TS) gene is associated with prognosis but not with response in neoadjuvant treated locally advanced (NTLA) gastric cancer (GC) (2004) (0)
- CHAPTER 11 PREDICTION OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN CARCINOMAS OF THE UPPER GASTROINTESTINAL TRACT (0)
- 837 Notch Signaling and Chemoresistance in Gastric Cancer (2012) (0)
- [Development of a technique for isolation of intact tumor cells from fresh breast or ovarian cancer tissue. Use in analysis of tumor-associated proteolytic factors]. (1993) (0)
- [Analysis of point mutations of Ha-ras gene in basaliomas and spinaliomas usiang the polymerase chain reaction (PCR) technic]. (1989) (0)
- [Opening address of the President. Molecular patholgy: challenge, risks and chance]. (2000) (0)
- [Experiences of the Bavarian mammography screening program]. (2006) (0)
- MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissues (2011) (0)
- Mutant E-cadherin as a new target for diagnosis and therapy of diffuse-type gastric cancer (1997) (0)
- S-phase fraction and ploidy as independent prognostic criteria in primary breast cancer and their correlation to tumor-cell associated proteases (1993) (0)
- [Organization and contents of future research in pathology]. (2001) (0)
- Prevalence and prognostic role of lymphatic vessel invasion remain unchanged after neoadjuvant chemotherapy of adenocarcinomas of the esophagogastric junction (2004) (0)
- Length polymorphism in the promoter of the thymidylate synthase (TS) gene is associated with prognosis but not with response in neoadjuvant treated locally advanced (NTLA) gastric cancer (GC). (2004) (0)
- HER2 status and UPA/PAI-1 provide complementary information on patient outcome in node-negative breast cancer (2003) (0)
- High HSP27 and HSP70 expression levels are independent adverse prognostic factors in primary resected colon cancer (2012) (0)
- POLYMERASE CHAIN REACTION ANALYSIS OF EPSTEINBARR VIRUS, CYTOMEGALOVIRUS AND HERPES SIMPLEX VIRUS DNA GENOME IN CUTANEOUS AND NODAL LESIONS OF ANAPLASTIC LARGE-CELL LYMPHOMAS (1994) (0)
- 384 Synergistically Reduced Malignancy of Human Breast Cancer Cells Due to Co-Silencing of HER2 and PTK6 (2012) (0)
- 11 - Role of Immunohistochemical Expression of E-Cadherin in Diffuse-Type Gastric Cancer (2006) (0)
- [Cytogenetic investigations in primary prostate carcinomas]. (1993) (0)
- [Oncogene expression as prognostic factor in malignant tumors]. (1988) (0)
- [Classical prognostic factors in breast cancer]. (1993) (0)
- Alterationen des Y Chromosoms in der Metaplasie-Dysplasie-Karzinom Sequenz im Barrett-Ösophagus (2007) (0)
- Molecular diagnosis of a Mycobacterium chelonae infection. (2001) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Heinrich Höfler?
Heinrich Höfler is affiliated with the following schools:
